Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Market Cap	4.90B +4.8%
Revenue (ttm)	668.70M +13.3%
Net Income	272.95M +0.5%
EPS	3.37 +0.2%
Shares Out	80.72M
PE Ratio	18.01
Forward PE	15.14
Dividend	1.37 (2.26%)
Ex-Dividend Date	Jul 9, 2025

Volume	337,032
Average Volume	558,386
Open	60.94
Previous Close	60.97
Day's Range	60.53 - 61.28
52-Week Range	55.01 - 88.96
Beta	0.40
RSI	43.42
Earnings Date	Apr 23, 2026

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 856
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688581

Financial Performance

In 2024, Hangzhou AGS MedTech's revenue was 636.63 million, an increase of 25.14% compared to the previous year's 508.75 million. Earnings were 293.39 million, an increase of 35.06%.